Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. TPTX Peers
See (TPTX) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TPTX | $75.49 | +0.12% | N/A | -13.55 | -$5.57 | N/A |
| VRTX | $435.32 | -2.65% | 111.79B | -114.56 | -$3.80 | N/A |
| REGN | $604.64 | -1.65% | 64.18B | 15.38 | $39.31 | +0.29% |
| SGEN | $228.74 | -0.07% | 43.15B | -57.19 | -$4.00 | N/A |
| ALNY | $292.58 | +0.31% | 38.15B | -133.60 | -$2.19 | N/A |
| ARGX | $584.95 | +1.15% | 35.72B | 45.81 | $12.77 | N/A |
| BNTX | $99.09 | -2.59% | 23.82B | -27.83 | -$3.56 | N/A |
| BGNE | $184.71 | +0.49% | 20.21B | -22.55 | -$8.19 | N/A |
| SMMT | $25.41 | +4.18% | 18.74B | -74.74 | -$0.34 | N/A |
| DNA-WT | $0.27 | -2.76% | 18.73B | N/A | N/A | N/A |
Stock Comparison
TPTX vs VRTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, VRTX has a market cap of 111.79B. Regarding current trading prices, TPTX is priced at $75.49, while VRTX trades at $435.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas VRTX's P/E ratio is -114.56. In terms of profitability, TPTX's ROE is -0.23%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, TPTX is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs REGN Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, REGN has a market cap of 64.18B. Regarding current trading prices, TPTX is priced at $75.49, while REGN trades at $604.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas REGN's P/E ratio is 15.38. In terms of profitability, TPTX's ROE is -0.23%, compared to REGN's ROE of +0.15%. Regarding short-term risk, TPTX is less volatile compared to REGN. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs SGEN Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, SGEN has a market cap of 43.15B. Regarding current trading prices, TPTX is priced at $75.49, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas SGEN's P/E ratio is -57.19. In terms of profitability, TPTX's ROE is -0.23%, compared to SGEN's ROE of -0.17%. Regarding short-term risk, TPTX is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs ALNY Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ALNY has a market cap of 38.15B. Regarding current trading prices, TPTX is priced at $75.49, while ALNY trades at $292.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ALNY's P/E ratio is -133.60. In terms of profitability, TPTX's ROE is -0.23%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, TPTX is less volatile compared to ALNY. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ARGX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ARGX has a market cap of 35.72B. Regarding current trading prices, TPTX is priced at $75.49, while ARGX trades at $584.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ARGX's P/E ratio is 45.81. In terms of profitability, TPTX's ROE is -0.23%, compared to ARGX's ROE of +0.16%. Regarding short-term risk, TPTX is less volatile compared to ARGX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs BNTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, BNTX has a market cap of 23.82B. Regarding current trading prices, TPTX is priced at $75.49, while BNTX trades at $99.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas BNTX's P/E ratio is -27.83. In terms of profitability, TPTX's ROE is -0.23%, compared to BNTX's ROE of -0.04%. Regarding short-term risk, TPTX is less volatile compared to BNTX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs BGNE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, BGNE has a market cap of 20.21B. Regarding current trading prices, TPTX is priced at $75.49, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas BGNE's P/E ratio is -22.55. In terms of profitability, TPTX's ROE is -0.23%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, TPTX is less volatile compared to BGNE. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs SMMT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, SMMT has a market cap of 18.74B. Regarding current trading prices, TPTX is priced at $75.49, while SMMT trades at $25.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas SMMT's P/E ratio is -74.74. In terms of profitability, TPTX's ROE is -0.23%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, TPTX is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs DNA-WT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, DNA-WT has a market cap of 18.73B. Regarding current trading prices, TPTX is priced at $75.49, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, TPTX's ROE is -0.23%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, TPTX is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs RPRX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RPRX has a market cap of 18.46B. Regarding current trading prices, TPTX is priced at $75.49, while RPRX trades at $32.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RPRX's P/E ratio is 13.40. In terms of profitability, TPTX's ROE is -0.23%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, TPTX is less volatile compared to RPRX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs UTHR Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, UTHR has a market cap of 13.97B. Regarding current trading prices, TPTX is priced at $75.49, while UTHR trades at $309.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas UTHR's P/E ratio is 12.57. In terms of profitability, TPTX's ROE is -0.23%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, TPTX is less volatile compared to UTHR. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs GMAB Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, GMAB has a market cap of 12.66B. Regarding current trading prices, TPTX is priced at $75.49, while GMAB trades at $20.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas GMAB's P/E ratio is 12.07. In terms of profitability, TPTX's ROE is -0.23%, compared to GMAB's ROE of +0.26%. Regarding short-term risk, TPTX is less volatile compared to GMAB. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs KRTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, KRTX has a market cap of 12.60B. Regarding current trading prices, TPTX is priced at $75.49, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas KRTX's P/E ratio is -28.09. In terms of profitability, TPTX's ROE is -0.23%, compared to KRTX's ROE of -0.25%. Regarding short-term risk, TPTX is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs INCY Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, INCY has a market cap of 12.54B. Regarding current trading prices, TPTX is priced at $75.49, while INCY trades at $64.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas INCY's P/E ratio is 323.90. In terms of profitability, TPTX's ROE is -0.23%, compared to INCY's ROE of +0.01%. Regarding short-term risk, TPTX is less volatile compared to INCY. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs EXEL Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, EXEL has a market cap of 11.92B. Regarding current trading prices, TPTX is priced at $75.49, while EXEL trades at $43.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas EXEL's P/E ratio is 19.96. In terms of profitability, TPTX's ROE is -0.23%, compared to EXEL's ROE of +0.29%. Regarding short-term risk, TPTX is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs BMRN Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, BMRN has a market cap of 11.22B. Regarding current trading prices, TPTX is priced at $75.49, while BMRN trades at $58.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas BMRN's P/E ratio is 21.66. In terms of profitability, TPTX's ROE is -0.23%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, TPTX is less volatile compared to BMRN. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs MRNA Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MRNA has a market cap of 9.98B. Regarding current trading prices, TPTX is priced at $75.49, while MRNA trades at $25.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MRNA's P/E ratio is -2.96. In terms of profitability, TPTX's ROE is -0.23%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, TPTX is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs RXDX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RXDX has a market cap of 9.56B. Regarding current trading prices, TPTX is priced at $75.49, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RXDX's P/E ratio is -56.47. In terms of profitability, TPTX's ROE is -0.23%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, TPTX is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs ASND Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ASND has a market cap of 9.55B. Regarding current trading prices, TPTX is priced at $75.49, while ASND trades at $158.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ASND's P/E ratio is -24.32. In terms of profitability, TPTX's ROE is -0.23%, compared to ASND's ROE of +1.91%. Regarding short-term risk, TPTX is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs IMGN Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, IMGN has a market cap of 8.73B. Regarding current trading prices, TPTX is priced at $75.49, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas IMGN's P/E ratio is -111.55. In terms of profitability, TPTX's ROE is -0.23%, compared to IMGN's ROE of +0.05%. Regarding short-term risk, TPTX is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs CERE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CERE has a market cap of 8.19B. Regarding current trading prices, TPTX is priced at $75.49, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CERE's P/E ratio is -16.47. In terms of profitability, TPTX's ROE is -0.23%, compared to CERE's ROE of -0.99%. Regarding short-term risk, TPTX is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs CORT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CORT has a market cap of 8.04B. Regarding current trading prices, TPTX is priced at $75.49, while CORT trades at $75.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CORT's P/E ratio is 65.91. In terms of profitability, TPTX's ROE is -0.23%, compared to CORT's ROE of +0.20%. Regarding short-term risk, TPTX is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ROIVW Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ROIVW has a market cap of 7.83B. Regarding current trading prices, TPTX is priced at $75.49, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, TPTX's ROE is -0.23%, compared to ROIVW's ROE of -0.02%. Regarding short-term risk, TPTX is less volatile compared to ROIVW. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ROIV Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ROIV has a market cap of 7.78B. Regarding current trading prices, TPTX is priced at $75.49, while ROIV trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ROIV's P/E ratio is -10.91. In terms of profitability, TPTX's ROE is -0.23%, compared to ROIV's ROE of -0.02%. Regarding short-term risk, TPTX is less volatile compared to ROIV. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs TECH Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, TECH has a market cap of 7.31B. Regarding current trading prices, TPTX is priced at $75.49, while TECH trades at $46.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas TECH's P/E ratio is 56.22. In terms of profitability, TPTX's ROE is -0.23%, compared to TECH's ROE of +0.06%. Regarding short-term risk, TPTX is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs RVMD Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RVMD has a market cap of 7.22B. Regarding current trading prices, TPTX is priced at $75.49, while RVMD trades at $38.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RVMD's P/E ratio is -9.66. In terms of profitability, TPTX's ROE is -0.23%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, TPTX is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs JAZZ Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, JAZZ has a market cap of 6.67B. Regarding current trading prices, TPTX is priced at $75.49, while JAZZ trades at $108.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas JAZZ's P/E ratio is 14.71. In terms of profitability, TPTX's ROE is -0.23%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, TPTX is less volatile compared to JAZZ. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs HALO Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, HALO has a market cap of 6.65B. Regarding current trading prices, TPTX is priced at $75.49, while HALO trades at $53.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas HALO's P/E ratio is 15.72. In terms of profitability, TPTX's ROE is -0.23%, compared to HALO's ROE of +1.22%. Regarding short-term risk, TPTX is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs RETA Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RETA has a market cap of 6.57B. Regarding current trading prices, TPTX is priced at $75.49, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RETA's P/E ratio is -66.29. In terms of profitability, TPTX's ROE is -0.23%, compared to RETA's ROE of +0.47%. Regarding short-term risk, TPTX is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs BPMC Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, BPMC has a market cap of 6.56B. Regarding current trading prices, TPTX is priced at $75.49, while BPMC trades at $101.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas BPMC's P/E ratio is -40.44. In terms of profitability, TPTX's ROE is -0.23%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, TPTX is less volatile compared to BPMC. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs VRNA Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, VRNA has a market cap of 6.30B. Regarding current trading prices, TPTX is priced at $75.49, while VRNA trades at $74.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas VRNA's P/E ratio is -37.04. In terms of profitability, TPTX's ROE is -0.23%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, TPTX is less volatile compared to VRNA. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs BBIO Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, BBIO has a market cap of 6.24B. Regarding current trading prices, TPTX is priced at $75.49, while BBIO trades at $32.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas BBIO's P/E ratio is -11.40. In terms of profitability, TPTX's ROE is -0.23%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, TPTX is less volatile compared to BBIO. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs MDGL Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MDGL has a market cap of 6.16B. Regarding current trading prices, TPTX is priced at $75.49, while MDGL trades at $277.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MDGL's P/E ratio is -15.55. In terms of profitability, TPTX's ROE is -0.23%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, TPTX is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs TLX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, TLX has a market cap of 5.56B. Regarding current trading prices, TPTX is priced at $75.49, while TLX trades at $16.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas TLX's P/E ratio is 184.67. In terms of profitability, TPTX's ROE is -0.23%, compared to TLX's ROE of +0.14%. Regarding short-term risk, TPTX is less volatile compared to TLX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ABCM Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ABCM has a market cap of 5.52B. Regarding current trading prices, TPTX is priced at $75.49, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, TPTX's ROE is -0.23%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, TPTX is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs ISEE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ISEE has a market cap of 5.51B. Regarding current trading prices, TPTX is priced at $75.49, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ISEE's P/E ratio is -22.44. In terms of profitability, TPTX's ROE is -0.23%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, TPTX is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs TGTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, TGTX has a market cap of 5.43B. Regarding current trading prices, TPTX is priced at $75.49, while TGTX trades at $34.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas TGTX's P/E ratio is 136.80. In terms of profitability, TPTX's ROE is -0.23%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, TPTX is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs IONS Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, IONS has a market cap of 5.33B. Regarding current trading prices, TPTX is priced at $75.49, while IONS trades at $33.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas IONS's P/E ratio is -11.20. In terms of profitability, TPTX's ROE is -0.23%, compared to IONS's ROE of -0.00%. Regarding short-term risk, TPTX is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs NUVL Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, NUVL has a market cap of 5.29B. Regarding current trading prices, TPTX is priced at $75.49, while NUVL trades at $73.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas NUVL's P/E ratio is -16.67. In terms of profitability, TPTX's ROE is -0.23%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, TPTX is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs AXSM Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, AXSM has a market cap of 5.21B. Regarding current trading prices, TPTX is priced at $75.49, while AXSM trades at $105.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas AXSM's P/E ratio is -18.30. In terms of profitability, TPTX's ROE is -0.23%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, TPTX is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ALKS Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ALKS has a market cap of 5.03B. Regarding current trading prices, TPTX is priced at $75.49, while ALKS trades at $30.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ALKS's P/E ratio is 14.54. In terms of profitability, TPTX's ROE is -0.23%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, TPTX is less volatile compared to ALKS. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ADMA Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ADMA has a market cap of 4.80B. Regarding current trading prices, TPTX is priced at $75.49, while ADMA trades at $20.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ADMA's P/E ratio is 23.95. In terms of profitability, TPTX's ROE is -0.23%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, TPTX is less volatile compared to ADMA. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ALPN Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ALPN has a market cap of 4.46B. Regarding current trading prices, TPTX is priced at $75.49, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ALPN's P/E ratio is -101.52. In terms of profitability, TPTX's ROE is -0.23%, compared to ALPN's ROE of -0.15%. Regarding short-term risk, TPTX is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs PCVX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, PCVX has a market cap of 4.38B. Regarding current trading prices, TPTX is priced at $75.49, while PCVX trades at $33.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas PCVX's P/E ratio is -8.51. In terms of profitability, TPTX's ROE is -0.23%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, TPTX is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs OPT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, OPT has a market cap of 4.20B. Regarding current trading prices, TPTX is priced at $75.49, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas OPT's P/E ratio is -1.52. In terms of profitability, TPTX's ROE is -0.23%, compared to OPT's ROE of +2.60%. Regarding short-term risk, TPTX is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs MRTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MRTX has a market cap of 4.12B. Regarding current trading prices, TPTX is priced at $75.49, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MRTX's P/E ratio is -4.82. In terms of profitability, TPTX's ROE is -0.23%, compared to MRTX's ROE of -0.40%. Regarding short-term risk, TPTX is less volatile compared to MRTX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs RYTM Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RYTM has a market cap of 3.97B. Regarding current trading prices, TPTX is priced at $75.49, while RYTM trades at $62.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RYTM's P/E ratio is -22.27. In terms of profitability, TPTX's ROE is -0.23%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, TPTX is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs SRPT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, SRPT has a market cap of 3.94B. Regarding current trading prices, TPTX is priced at $75.49, while SRPT trades at $40.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas SRPT's P/E ratio is -15.17. In terms of profitability, TPTX's ROE is -0.23%, compared to SRPT's ROE of -0.20%. Regarding short-term risk, TPTX is less volatile compared to SRPT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs AKRO Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, AKRO has a market cap of 3.85B. Regarding current trading prices, TPTX is priced at $75.49, while AKRO trades at $48.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas AKRO's P/E ratio is -12.89. In terms of profitability, TPTX's ROE is -0.23%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, TPTX is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs RYZB Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RYZB has a market cap of 3.75B. Regarding current trading prices, TPTX is priced at $75.49, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RYZB's P/E ratio is -57.86. In terms of profitability, TPTX's ROE is -0.23%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, TPTX is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs CYTK Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CYTK has a market cap of 3.74B. Regarding current trading prices, TPTX is priced at $75.49, while CYTK trades at $31.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CYTK's P/E ratio is -5.92. In terms of profitability, TPTX's ROE is -0.23%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, TPTX is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs CBAY Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CBAY has a market cap of 3.73B. Regarding current trading prices, TPTX is priced at $75.49, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CBAY's P/E ratio is -32.81. In terms of profitability, TPTX's ROE is -0.23%, compared to CBAY's ROE of -0.32%. Regarding short-term risk, TPTX is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs SLNO Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, SLNO has a market cap of 3.69B. Regarding current trading prices, TPTX is priced at $75.49, while SLNO trades at $73.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas SLNO's P/E ratio is -15.46. In terms of profitability, TPTX's ROE is -0.23%, compared to SLNO's ROE of -0.78%. Regarding short-term risk, TPTX is less volatile compared to SLNO. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs RNA Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RNA has a market cap of 3.69B. Regarding current trading prices, TPTX is priced at $75.49, while RNA trades at $30.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RNA's P/E ratio is -10.21. In terms of profitability, TPTX's ROE is -0.23%, compared to RNA's ROE of -0.27%. Regarding short-term risk, TPTX is less volatile compared to RNA. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs PTCT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, PTCT has a market cap of 3.66B. Regarding current trading prices, TPTX is priced at $75.49, while PTCT trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas PTCT's P/E ratio is -9.77. In terms of profitability, TPTX's ROE is -0.23%, compared to PTCT's ROE of -0.72%. Regarding short-term risk, TPTX is less volatile compared to PTCT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs KRYS Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, KRYS has a market cap of 3.66B. Regarding current trading prices, TPTX is priced at $75.49, while KRYS trades at $126.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas KRYS's P/E ratio is 42.37. In terms of profitability, TPTX's ROE is -0.23%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, TPTX is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ACAD Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ACAD has a market cap of 3.66B. Regarding current trading prices, TPTX is priced at $75.49, while ACAD trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ACAD's P/E ratio is 15.95. In terms of profitability, TPTX's ROE is -0.23%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, TPTX is less volatile compared to ACAD. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ACLX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ACLX has a market cap of 3.61B. Regarding current trading prices, TPTX is priced at $75.49, while ACLX trades at $65.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ACLX's P/E ratio is -21.92. In terms of profitability, TPTX's ROE is -0.23%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, TPTX is less volatile compared to ACLX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs SWTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, SWTX has a market cap of 3.48B. Regarding current trading prices, TPTX is priced at $75.49, while SWTX trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas SWTX's P/E ratio is -13.55. In terms of profitability, TPTX's ROE is -0.23%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, TPTX is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs RARE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, RARE has a market cap of 3.35B. Regarding current trading prices, TPTX is priced at $75.49, while RARE trades at $35.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas RARE's P/E ratio is -6.08. In terms of profitability, TPTX's ROE is -0.23%, compared to RARE's ROE of -1.86%. Regarding short-term risk, TPTX is less volatile compared to RARE. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs CRSP Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CRSP has a market cap of 3.19B. Regarding current trading prices, TPTX is priced at $75.49, while CRSP trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CRSP's P/E ratio is -8.24. In terms of profitability, TPTX's ROE is -0.23%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, TPTX is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs VKTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, VKTX has a market cap of 3.06B. Regarding current trading prices, TPTX is priced at $75.49, while VKTX trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas VKTX's P/E ratio is -23.49. In terms of profitability, TPTX's ROE is -0.23%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, TPTX is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs MTSR Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MTSR has a market cap of 3.01B. Regarding current trading prices, TPTX is priced at $75.49, while MTSR trades at $28.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MTSR's P/E ratio is -11.34. In terms of profitability, TPTX's ROE is -0.23%, compared to MTSR's ROE of -0.63%. Regarding short-term risk, TPTX is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs MRUS Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MRUS has a market cap of 2.99B. Regarding current trading prices, TPTX is priced at $75.49, while MRUS trades at $43.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MRUS's P/E ratio is -10.39. In terms of profitability, TPTX's ROE is -0.23%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, TPTX is less volatile compared to MRUS. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs CPRX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CPRX has a market cap of 2.97B. Regarding current trading prices, TPTX is priced at $75.49, while CPRX trades at $24.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CPRX's P/E ratio is 15.49. In terms of profitability, TPTX's ROE is -0.23%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, TPTX is less volatile compared to CPRX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs SRRK Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, SRRK has a market cap of 2.92B. Regarding current trading prices, TPTX is priced at $75.49, while SRRK trades at $30.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas SRRK's P/E ratio is -12.05. In terms of profitability, TPTX's ROE is -0.23%, compared to SRRK's ROE of -1.18%. Regarding short-term risk, TPTX is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs MORF Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MORF has a market cap of 2.86B. Regarding current trading prices, TPTX is priced at $75.49, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MORF's P/E ratio is -14.88. In terms of profitability, TPTX's ROE is -0.23%, compared to MORF's ROE of -0.27%. Regarding short-term risk, TPTX is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs MOR Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MOR has a market cap of 2.86B. Regarding current trading prices, TPTX is priced at $75.49, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MOR's P/E ratio is -12.64. In terms of profitability, TPTX's ROE is -0.23%, compared to MOR's ROE of +7.43%. Regarding short-term risk, TPTX is less volatile compared to MOR. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs PTGX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, PTGX has a market cap of 2.84B. Regarding current trading prices, TPTX is priced at $75.49, while PTGX trades at $45.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas PTGX's P/E ratio is 58.74. In terms of profitability, TPTX's ROE is -0.23%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, TPTX is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs CRNX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CRNX has a market cap of 2.81B. Regarding current trading prices, TPTX is priced at $75.49, while CRNX trades at $29.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CRNX's P/E ratio is -7.88. In terms of profitability, TPTX's ROE is -0.23%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, TPTX is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs KDNY Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, KDNY has a market cap of 2.71B. Regarding current trading prices, TPTX is priced at $75.49, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas KDNY's P/E ratio is -12.47. In terms of profitability, TPTX's ROE is -0.23%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, TPTX is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs MYOV Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MYOV has a market cap of 2.62B. Regarding current trading prices, TPTX is priced at $75.49, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MYOV's P/E ratio is -14.05. In terms of profitability, TPTX's ROE is -0.23%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, TPTX is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs LEGN Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, LEGN has a market cap of 2.61B. Regarding current trading prices, TPTX is priced at $75.49, while LEGN trades at $28.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas LEGN's P/E ratio is -24.01. In terms of profitability, TPTX's ROE is -0.23%, compared to LEGN's ROE of -0.20%. Regarding short-term risk, TPTX is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs IMVT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, IMVT has a market cap of 2.45B. Regarding current trading prices, TPTX is priced at $75.49, while IMVT trades at $14.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas IMVT's P/E ratio is -5.50. In terms of profitability, TPTX's ROE is -0.23%, compared to IMVT's ROE of -0.78%. Regarding short-term risk, TPTX is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs MLTX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MLTX has a market cap of 2.45B. Regarding current trading prices, TPTX is priced at $75.49, while MLTX trades at $38.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MLTX's P/E ratio is -21.53. In terms of profitability, TPTX's ROE is -0.23%, compared to MLTX's ROE of -0.00%. Regarding short-term risk, TPTX is less volatile compared to MLTX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs APGE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, APGE has a market cap of 2.39B. Regarding current trading prices, TPTX is priced at $75.49, while APGE trades at $40.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas APGE's P/E ratio is -11.13. In terms of profitability, TPTX's ROE is -0.23%, compared to APGE's ROE of -0.19%. Regarding short-term risk, TPTX is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs PRVB Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, PRVB has a market cap of 2.38B. Regarding current trading prices, TPTX is priced at $75.49, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas PRVB's P/E ratio is -16.43. In terms of profitability, TPTX's ROE is -0.23%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, TPTX is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs LBPH Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, LBPH has a market cap of 2.34B. Regarding current trading prices, TPTX is priced at $75.49, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas LBPH's P/E ratio is -26.66. In terms of profitability, TPTX's ROE is -0.23%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, TPTX is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for TPTX.
TPTX vs IBRX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, IBRX has a market cap of 2.34B. Regarding current trading prices, TPTX is priced at $75.49, while IBRX trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas IBRX's P/E ratio is -4.65. In terms of profitability, TPTX's ROE is -0.23%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, TPTX is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs XENE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, XENE has a market cap of 2.34B. Regarding current trading prices, TPTX is priced at $75.49, while XENE trades at $30.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas XENE's P/E ratio is -9.46. In terms of profitability, TPTX's ROE is -0.23%, compared to XENE's ROE of -0.32%. Regarding short-term risk, TPTX is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs DICE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, DICE has a market cap of 2.27B. Regarding current trading prices, TPTX is priced at $75.49, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas DICE's P/E ratio is -21.91. In terms of profitability, TPTX's ROE is -0.23%, compared to DICE's ROE of +0.56%. Regarding short-term risk, TPTX is less volatile compared to DICE. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs MIRM Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, MIRM has a market cap of 2.19B. Regarding current trading prices, TPTX is priced at $75.49, while MIRM trades at $44.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas MIRM's P/E ratio is -25.32. In terms of profitability, TPTX's ROE is -0.23%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, TPTX is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs BLTE Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, BLTE has a market cap of 2.19B. Regarding current trading prices, TPTX is priced at $75.49, while BLTE trades at $67.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas BLTE's P/E ratio is -49.48. In terms of profitability, TPTX's ROE is -0.23%, compared to BLTE's ROE of -0.31%. Regarding short-term risk, TPTX is less volatile compared to BLTE. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs APLS Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, APLS has a market cap of 2.19B. Regarding current trading prices, TPTX is priced at $75.49, while APLS trades at $17.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas APLS's P/E ratio is -9.68. In terms of profitability, TPTX's ROE is -0.23%, compared to APLS's ROE of -1.00%. Regarding short-term risk, TPTX is less volatile compared to APLS. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs AAPG Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, AAPG has a market cap of 2.18B. Regarding current trading prices, TPTX is priced at $75.49, while AAPG trades at $25.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas AAPG's P/E ratio is -34.38. In terms of profitability, TPTX's ROE is -0.23%, compared to AAPG's ROE of -2.50%. Regarding short-term risk, TPTX is less volatile compared to AAPG. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs VCYT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, VCYT has a market cap of 2.16B. Regarding current trading prices, TPTX is priced at $75.49, while VCYT trades at $27.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas VCYT's P/E ratio is 65.69. In terms of profitability, TPTX's ROE is -0.23%, compared to VCYT's ROE of +0.03%. Regarding short-term risk, TPTX is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs CALT Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CALT has a market cap of 2.15B. Regarding current trading prices, TPTX is priced at $75.49, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CALT's P/E ratio is -22.73. In terms of profitability, TPTX's ROE is -0.23%, compared to CALT's ROE of -2.10%. Regarding short-term risk, TPTX is less volatile compared to CALT. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs ARWR Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, ARWR has a market cap of 2.11B. Regarding current trading prices, TPTX is priced at $75.49, while ARWR trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas ARWR's P/E ratio is -12.35. In terms of profitability, TPTX's ROE is -0.23%, compared to ARWR's ROE of -0.46%. Regarding short-term risk, TPTX is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs BCRX Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, BCRX has a market cap of 2.11B. Regarding current trading prices, TPTX is priced at $75.49, while BCRX trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas BCRX's P/E ratio is -38.73. In terms of profitability, TPTX's ROE is -0.23%, compared to BCRX's ROE of +0.11%. Regarding short-term risk, TPTX is less volatile compared to BCRX. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs NAMS Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, NAMS has a market cap of 2.07B. Regarding current trading prices, TPTX is priced at $75.49, while NAMS trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas NAMS's P/E ratio is -10.03. In terms of profitability, TPTX's ROE is -0.23%, compared to NAMS's ROE of -0.26%. Regarding short-term risk, TPTX is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs VCEL Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, VCEL has a market cap of 2.07B. Regarding current trading prices, TPTX is priced at $75.49, while VCEL trades at $41.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas VCEL's P/E ratio is 205.35. In terms of profitability, TPTX's ROE is -0.23%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, TPTX is less volatile compared to VCEL. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs CGON Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, CGON has a market cap of 2.00B. Regarding current trading prices, TPTX is priced at $75.49, while CGON trades at $26.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas CGON's P/E ratio is -17.48. In terms of profitability, TPTX's ROE is -0.23%, compared to CGON's ROE of -0.11%. Regarding short-term risk, TPTX is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs DNLI Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, DNLI has a market cap of 1.99B. Regarding current trading prices, TPTX is priced at $75.49, while DNLI trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas DNLI's P/E ratio is -5.13. In terms of profitability, TPTX's ROE is -0.23%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, TPTX is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs HRMY Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, HRMY has a market cap of 1.98B. Regarding current trading prices, TPTX is priced at $75.49, while HRMY trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas HRMY's P/E ratio is 13.17. In terms of profitability, TPTX's ROE is -0.23%, compared to HRMY's ROE of +0.24%. Regarding short-term risk, TPTX is less volatile compared to HRMY. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs LGND Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, LGND has a market cap of 1.98B. Regarding current trading prices, TPTX is priced at $75.49, while LGND trades at $102.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas LGND's P/E ratio is -14.05. In terms of profitability, TPTX's ROE is -0.23%, compared to LGND's ROE of -0.16%. Regarding short-term risk, TPTX is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs NAMSW Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, NAMSW has a market cap of 1.96B. Regarding current trading prices, TPTX is priced at $75.49, while NAMSW trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas NAMSW's P/E ratio is N/A. In terms of profitability, TPTX's ROE is -0.23%, compared to NAMSW's ROE of -0.26%. Regarding short-term risk, TPTX is less volatile compared to NAMSW. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs KYMR Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, KYMR has a market cap of 1.96B. Regarding current trading prices, TPTX is priced at $75.49, while KYMR trades at $30.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas KYMR's P/E ratio is -9.69. In terms of profitability, TPTX's ROE is -0.23%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, TPTX is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs FOLD Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, FOLD has a market cap of 1.95B. Regarding current trading prices, TPTX is priced at $75.49, while FOLD trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas FOLD's P/E ratio is -70.44. In terms of profitability, TPTX's ROE is -0.23%, compared to FOLD's ROE of -0.17%. Regarding short-term risk, TPTX is less volatile compared to FOLD. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.
TPTX vs GLPG Comparison
TPTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TPTX stands at N/A. In comparison, GLPG has a market cap of 1.91B. Regarding current trading prices, TPTX is priced at $75.49, while GLPG trades at $28.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TPTX currently has a P/E ratio of -13.55, whereas GLPG's P/E ratio is -9.50. In terms of profitability, TPTX's ROE is -0.23%, compared to GLPG's ROE of -0.06%. Regarding short-term risk, TPTX is less volatile compared to GLPG. This indicates potentially lower risk in terms of short-term price fluctuations for TPTX.